Skip to main content

Weight Loss (Obesity / Overweight) News (Page 13)

Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications

Disparities Exist in Use of Obesity-Management Medications

THURSDAY, Jan. 2, 2025 – Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online Dec. 17 in the Journal of Racial and Ethnic Health ...

How do GLP-1s Boost Weight Loss, Heart Health?

THURSDAY, Jan. 2, 2024 – Weight loss tops many folks’ list of New Years resolutions, and lots of people are turning to cutting-edge weight-loss drugs like Ozempic to help them drop excess pounds. T...

Odds of Metabolic Disease Lower With Fast Subjective Walking Speed in Patients With Obesity

MONDAY, Dec. 30, 2024 – Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity, according to a study published online Nov. 15 in Scientific...

Guidance Issued for Use of Metformin to Prevent Antipsychotic-Induced Weight Gain

MONDAY, Dec. 30, 2024 – In a guideline published online Dec. 9 in Schizophrenia Bulletin, recommendations are presented for the use of metformin to prevent antipsychotic-induced weight gain (AIWG)....

30 Minutes of Aerobic Exercise Weekly Cuts Body Fat in Adults With Overweight or Obesity

MONDAY, Dec. 30, 2024 – Among adults with overweight or obesity, 30 minutes of aerobic exercise per week is associated with moderate reductions in body weight, waist circumference, and body fat...

Weight-Loss Drugs, Wily Viruses, Abortion Pill Under Attack: The Top Health Stories of 2024

MONDAY, Dec. 30, 2024 – It was a year in health news that will be hard to forget. As blockbuster weight-loss drugs known as GLP-1s made a sizable dent in the obesity epidemic, study after study...

Rhythm Pharmaceuticals Announces FDA Approval of Imcivree (setmelanotide) for Patients as Young as 2 Years Old

BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) – Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare...

FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only...

2023 Saw Decline in BMI, Obesity Prevalence in the United States

MONDAY, Dec. 23, 2024 – Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published online Dec. 13 in JAMA Health Forum. Benjamin...

Milk Cereal Drinks for Infants May Trigger Weight Gain

THURSDAY, Dec. 19, 2024 – Adding cereal to a baby’s bottle is a habit that’s been around for a long time to help introduce solid foods while also supplementing a mom’s breast milk. But this practice ...

FDA Says Shortage of GLP-1 Tirzepatide (Mounjaro, Zepbound) Is Over

THURSDAY, Dec. 19, 2024 – The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over....

Artificial Sweetener Use Tied to Less-Healthy Diets

WEDNESDAY, Dec. 18, 2024 – Folks who switch to artificial sweeteners in drinks and food may be drawn to other types of unhealthy fare – bringing down the quality of their overall diet, new research...

Breast Cancer Risk Increased With Weight Gain After Age 35 Years

WEDNESDAY, Dec. 18, 2024 – The risk for breast cancer is increased with weight gain after age 35 years, according to a research letter recently published in Cancer Biology & Medicine. Katherine De...

Colon Cancer Rates Are Up Among the Young Worldwide

MONDAY, Dec. 16, 2024 – More young people around the world are falling prey to colon cancer, a new study shows. Colon cancer rates in young adults have risen in 27 out of 50 countries around the...

U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose

FRIDAY, Dec. 13, 2024 – The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss meds, a new study finds. Data on almost 17 million...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, tirzepatide, Adipex-P, Alli, orlistat, dulaglutide, garcinia cambogia, desvenlafaxine